Conferences

European AIDS Clinical Society Conference 2015

The 15th European AIDS Conference, organised by the European AIDS Clinical Society (EACS), took place in Barcelona, Spain, from 21-24 October 2015. NAM is the official provider of online science news.
Treatment guidelines

With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006

HIV prevention policy

Can Europe reach the 90-90-90 target for HIV treatment by 2020?

PrEP programmes & uptake

Barcelona clinic study counts how many gay men might benefit from PrEP

Women

Women living with HIV in the UK continue to have poorer treatment outcomes

How HIV works

Does low-level HIV viral load raise the risk of disease progression and co-morbidities?

Hepatitis C transmission & prevention

Hepatitis C incidence remains stable among gay men living with HIV in Europe, but varies across countries

HIV treatment

Priorities for HIV care: the perspectives of healthcare providers and patients

Hepatitis C treatment

Sofosbuvir/ledipasvir for 8 weeks cures most hard-to-treat hepatitis C patients in real-world study

Hepatitis & HIV

Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co-infection

New & experimental HIV treatments

HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial

Neurological & cognitive problems

START sub-studies show no differences in lung or neurocognitive function with early or later treatment

Bone & joint problems

START sub-study shows more bone loss with earlier HIV treatment

Chemsex & recreational drug use

London clinic survey shows impact of chemsex on condom and PEP use

Cardiovascular disease

Risk of heart attack rises with length of HIV infection, regardless of age

New & experimental HIV treatments

Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety

PrEP

When will Europe get PrEP?

Treatment simplification strategies

Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?

Migrants, refugees & displaced people

The majority of migrants living with HIV in Europe may have acquired HIV in their new country

HIV treatment

Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved

Drug-resistant TB

Newest MDR-TB drug prices could fall by up to 95% through generic production

TB diagnosis

TB death rate four times higher in Eastern Europe due to lack of HIV treatment after TB diagnosis

TB transmission & prevention

Three-month isoniazid/pyrazinamide regimen prevents TB as well as 6-month isoniazid in people living with HIV

PrEP science

Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis